Pfizer Inc. (PFE)
- Previous Close
27.70 - Open
27.86 - Bid 27.90 x 2900
- Ask 27.90 x 2200
- Day's Range
27.52 - 27.91 - 52 Week Range
25.20 - 40.37 - Volume
60,568,852 - Avg. Volume
41,164,450 - Market Cap (intraday)
157.475B - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-0.05 - Earnings Date Jul 30, 2024 - Aug 5, 2024
- Forward Dividend & Yield 1.68 (6.04%)
- Ex-Dividend Date May 9, 2024
- 1y Target Est
31.37
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
www.pfizer.com88,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PFE
Related Videos: PFE
Performance Overview: PFE
Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PFE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PFE
Valuation Measures
Market Cap
157.48B
Enterprise Value
215.63B
Trailing P/E
--
Forward P/E
12.76
PEG Ratio (5yr expected)
0.28
Price/Sales (ttm)
2.85
Price/Book (mrq)
1.77
Enterprise Value/Revenue
3.91
Enterprise Value/EBITDA
37.00
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.56%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
54.89B
Net Income Avi to Common (ttm)
-288M
Diluted EPS (ttm)
-0.05
Balance Sheet and Cash Flow
Total Cash (mrq)
12.69B
Total Debt/Equity (mrq)
84.37%
Levered Free Cash Flow (ttm)
--
Research Analysis: PFE
Company Insights: PFE
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: PFE
Analyst Report: Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
RatingPrice TargetAnalyst Report: Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
RatingPrice TargetTechnical Assessment: Neutral in the Intermediate-Term
The stock market is in a rough patch for the first time since the July to October period of last year. After the major indices hit their secondary highs on April 11 (the Nasdaq hit its all-time high that day), is has pretty much been "down periscope." Out of those trading six days, the S&P 500 (SPX), Nasdaq, and Nasdaq 100 (QQQ) have fallen between 0.9% and 2.1% on three (SPX) or four of those days. Despite the very steep downside slope of the Big 3, NYSE breadth actually bottomed on April 12 and 15, illustrating that the selling has been concentrated in Big Tech and the many stocks that were overly extended on a momentum basis.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, European interest-rate cuts on the horizon; firm opportunities among drug and biopharma firms; and reports Tesla's affordable vehicle will be canceled; and Lazard, PVH, and Genmab.